NAS:ARPO (USA) Also trade in: Germany

Aerpio Pharmaceuticals Inc

$ 0.81 -0.01 (-1.78%)
Volume: 47,087 Avg Vol (1m): 177,490
Market Cap $: 32.87 Mil Enterprise Value $: -20,030,000.00
P/E (TTM): 0.00 P/B: 0.65
Earnings Power Value 0
Net Current Asset Value 1.23
Tangible Book 1.25
Projected FCF 0
Median P/S Value 2.4
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 9.3/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 101.18
Cash-To-Debt range over the past 10 years
Min: 0.05, Med: 10000, Max: 10000
Current: 101.18
0.05
10000
Equity-to-Asset 0.92
Equity-to-Asset range over the past 10 years
Min: 0.69, Med: 0.92, Max: 0.95
Current: 0.92
0.69
0.95
Debt-to-Equity 0.01
Debt-to-Equity range over the past 10 years
Min: -0.86, Med: -0.82, Max: 0.01
Current: 0.01
-0.86
0.01
Debt-to-EBITDA -0.04
Debt-to-EBITDA range over the past 10 years
Min: -6.96, Med: -3.85, Max: -0.04
Current: -0.04
-6.96
-0.04
Piotroski F-Score 4
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.28
DISTRESS
GREY
SAFE

Profitability & Growth : 3/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -62.13
Operating Margin range over the past 10 years
Min: -62.13, Med: -55.44, Max: -55.44
Current: -62.13
-62.13
-55.44
Net Margin % -56.88
Net Margin range over the past 10 years
Min: -56.88, Med: -51.58, Max: -51.58
Current: -56.88
-56.88
-51.58
ROE % -24.39
ROE range over the past 10 years
Min: -27.32, Med: -27.32, Max: -24.39
Current: -24.39
-27.32
-24.39
ROA % -20.95
ROA range over the past 10 years
Min: -1405.96, Med: -172.94, Max: -20.95
Current: -20.95
-1405.96
-20.95
ROC (Joel Greenblatt) % -5636.36
ROC (Joel Greenblatt) range over the past 10 years
Min: -22178.67, Med: -16571.98, Max: -5636.36
Current: -5636.36
-22178.67
-5636.36
3-Year Total EBITDA Growth Rate -685.00
N/A

» ARPO's 30-Y Financials

Financials (Next Earnings Date: 2019-08-14)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:ARPO

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Biotechnology » Biotechnology    NAICS : 325412    SIC : 2834
Compare LSE:TRX NAS:CFRX OTCPK:RASP NAS:COCP TSE:7776 XKRX:043090 NAS:CDMO NAS:EVFM OTCPK:CNBX TSE:2370 XPAR:ADVIC XCNQ:THC XKRX:041910 XKRX:067370 NAS:MDWD NAS:ACER NAS:FWP NAS:ORGS NAS:AFMD NAS:VTVT
Traded in other countries 335.Germany
Address 9987 Carver Road, Cincinnati, OH, USA, 45242
Aerpio Pharmaceuticals Inc is a biopharmaceutical company. It focuses on advancing first-in-class treatments for ocular diseases.

Ratios

Current vs industry vs history
PB Ratio 0.65
PB Ratio range over the past 10 years
Min: 0.64, Med: 1.53, Max: 3.4
Current: 0.65
0.64
3.4
PS Ratio 1.59
PS Ratio range over the past 10 years
Min: 1.57, Med: 4.73, Max: 85.71
Current: 1.59
1.57
85.71
EV-to-EBIT 1.61
EV-to-EBIT range over the past 10 years
Min: -9.5, Med: -1.5, Max: 1.63
Current: 1.61
-9.5
1.63
EV-to-EBITDA 1.61
EV-to-EBITDA range over the past 10 years
Min: -9.6, Med: -1.5, Max: 1.64
Current: 1.61
-9.6
1.64
EV-to-Revenue -0.99
EV-to-Revenue range over the past 10 years
Min: -1, Med: 1.55, Max: 34.5
Current: -0.99
-1
34.5
Current Ratio 13.84
Current Ratio range over the past 10 years
Min: 0.04, Med: 5.82, Max: 19.22
Current: 13.84
0.04
19.22
Quick Ratio 13.84
Quick Ratio range over the past 10 years
Min: 0.04, Med: 5.82, Max: 19.22
Current: 13.84
0.04
19.22

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -14.50
N/A

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 0.65
Price-to-Tangible-Book range over the past 10 years
Min: 0.64, Med: 3.36, Max: 11.61
Current: 0.65
0.64
11.61
Price-to-Median-PS-Value 0.34
Price-to-Median-PS-Value range over the past 10 years
Min: 0.32, Med: 0.92, Max: 16.6
Current: 0.34
0.32
16.6
Earnings Yield (Joel Greenblatt) % 62.67
Earnings Yield (Greenblatt) range over the past 10 years
Min: -161.6, Med: -17.3, Max: 168.4
Current: 62.67
-161.6
168.4

More Statistics

Revenue (TTM) (Mil) $ 20.16
EPS (TTM) $ -0.36
Beta 0
Volatility % 140.46
52-Week Range $ 0.75 - 4.3
Shares Outstanding (Mil) 40.59

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 4
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y